Sal Patel, JD: How Sandoz v Amgen Changed the Biosimilars Landscape

Transcript

How has last year’s Supreme Court ruling in Sandoz v Amgen changed the biosimilars landscape?

Well, it changes the biosimilar landscape in that now, biosimilar developers can go ahead and file declaratory judgment actions. They don’t need to participate in that long and tortuous patent dance that was required. I think it makes it a little bit easier for biosimilar developers.